✨ Medicines and Industrial Hemp Regulations




NEW ZEALAND GAZETTE, No. 105

7 SEPTEMBER 2006

3088

Product:
Dantrium

Active Ingredient:
Dantrolene sodium 50mg

Dosage Form:
Capsule, powder filled

New Zealand Sponsor:
Pfizer New Zealand Limited

Manufacturer:
Procter & Gamble Pharmaceuticals Puerto Rico Inc, Bo. Cotto Norte, Manati, Puerto Rico

Product:
Zantac Relief Extra Strength

Active Ingredient:
Ranitidine hydrochloride 336mg equivalent ranitidine 300mg

Dosage Form:
Tablet

New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited

Manufacturer:
GlaxoSmithKline Australia Pty Limited, Boronia, Victoria, Australia

Dated this 31st day of August 2006.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6145

Renewal of Provisional Consent to the Distribution of New Medicines

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Orgalutran

Active Ingredient:
Ganirelix 0.5mg/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Pharmaco (NZ) Limited

Manufacturer:
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany

Note: This consent is valid for two years from 9 November 2006.

Product:
Tracleer

Active Ingredient:
Bosentan 125mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics

Manufacturer:
Patheon Inc, Mississauga, Ontario, Canada

Note: This consent is valid for two years from 16 December 2006.\n
Product:
Tracleer

Active Ingredient:
Bosentan 62.5mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics

Manufacturer:
Patheon Inc, Mississauga, Ontario, Canada

Note: This consent is valid for two years from 16 December 2006.

Product:
Ursofalk

Active Ingredient:
Ursodeoxycholic acid 250mg

Dosage Form:
Capsule

New Zealand Sponsor:
St Ives Medical

Manufacturer:
Losan Pharma GmbH, Neuenburg, Germany

Note: This consent is valid for two years from 28 October 2006.

Dated this 31st day of August 2006.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6146

Misuse of Drugs (Industrial Hemp) Regulations 2006

Schedule of Approved Cultivars of Industrial Hemp

Finola
Kompolti
USO31
Fasamo
Anka

Pursuant to Regulation 5 (1) of the Misuse of Drugs (Industrial Hemp) Regulations 2006, I, Stephen McKernan, Director-General of Health, hereby approve the cultivars of industrial hemp described below for the purposes of that Regulation.

Dated at Wellington this 21st day of August 2006.

STEPHEN McKERNAN, Director-General of Health.

go6107



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2006, No 105


Gazette.govt.nz PDF NZ Gazette 2006, No 105





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
31 August 2006
Medicines, Distribution, Dantrium, Zantac Relief Extra Strength
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Renewal of Provisional Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
31 August 2006
Medicines, Provisional Consent, Orgalutran, Tracleer, Ursofalk
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Schedule of Approved Cultivars of Industrial Hemp

πŸ₯ Health & Social Welfare
21 August 2006
Industrial Hemp, Cultivars, Finola, Kompolti, USO31, Fasamo, Anka
  • STEPHEN McKERNAN, Director-General of Health